(Q41722642)

English

Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells

scientific article published on September 1990

Statements

Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells (English)
1 September 1990
333-339

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit